This is a randomized, open-label pilot study to assess whether treatment with chlorhexidine mouthwash can alter the esophageal and gastric cardia microbiome
Patients scheduled for upper endoscopy for clinical indications will be randomized to 3 weeks of either no treatment or use of twice daily chlorhexidine mouthwash leading up to the endoscopy. There will be 2-3 study visits, at Day 0 and Day 21, and for those subjects in the mouthwash arm, a final visit 1-2 weeks following the Day 21 visit. Subjects will be required to fast overnight prior to the visits on Days 0 and 21.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Chlorhexidine gluconate is a germicidal mouthwash that reduces bacteria in the mouth.
Columbia University Medical Center
New York, New York, United States
Reduction of F. Nucleatum in Saliva
Within individual change in relative abundance of F nucleatum in oral samples
Time frame: 21 days
Difference in Esophageal F. Nucleatum Between Experimental Group and no Intervention Group
Comparison of relative abundance of esophageal F. nucleatum in the mouthwash group vs. the no intervention group.
Time frame: 21 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.